Screening
Recommendation
Tobacco
Screening questions (tobacco use and readiness to quit)
Dietary habits and BMI
Screening questions (eating disorders, body image issues, and weight)
Alcohol/drugs
Screening questions (alcohol and drug misuse/abuse)
Mental health
Screening questions (depression, suicide, and anxiety)
Injuries/violence
Screening questions (intimate partner violence, victimization, and trauma)
Sexual behaviors
Screening questions (5 Ps: partners, practices, protection from STIs, past history of STIs, and prevention of pregnancy)
Gonorrhea/chlamydia
Screening as indicateda (test all exposed sites: urethra/urine, rectum, and pharynx)
Syphilis
Screening as indicateda
Hepatitis B
Screening as indicateda
Hepatitis C
Screening as indicateda (one time if born between 1945 and 1965 is recommended for the general population)
HIV
Screening as indicateda (one time for age 15–65 years is recommended for the general population)
Anal cancer
Some advocates recommend screening every 3 years with anal Pap and annually/biannually if HIV positive based on CD4 count
Immunizations
Recommendation
Hepatitis A
Vaccinate at any age with 2-dose series if not done previously
Hepatitis B
Vaccinate at any age with 3-dose series if not done previously
Human papillomavirus
Vaccinate at age 13–26 with 3-dose series if not done previously
Preventive medications
Recommendation
Postexposure prophylaxis (PEP)
Start antiretroviral regimen within 72 h of HIV exposure and continue for 28 days; follow-up with periodic HIV testing
Preexposure prophylaxis (PrEP)
Consider once-daily antiretroviral regimen for significant ongoing HIV exposure risk with follow-up HIV/STI testing, side effect monitoring, and safe sex counseling every 90 days
Counseling
Recommendation
Coming-out/support systems, legal concerns, smoking, dietary habits, obesity, alcohol and drug use, depression, violence, safe sex practices, family planning, and HIV prevention
Periodically counsel on topics as indicated based on responses to screening questions and risk factors
Welcoming Environment/Cultural Competency
Based on population prevalence, it is estimated that 3–4 % of male patients seen in clinics should be MSM. However, 47 % of MSM in one study never discussed their sexual orientation with their healthcare provider, 28 % felt uncomfortable coming out to their clinician, and 15 % had been treated poorly when they did come out [17].
Clinicians who do not know the sexual orientation of MSM provide fewer recommended health services [18–20]. MSM may delay or avoid healthcare because of previous negative experiences with the healthcare system, fear of potential discrimination, and concerns about confidentiality. Clinicians should complete additional training to become culturally and medically competent to identify sexual orientation/gender identity and to address the healthcare issues of MSM [11]. Some of the ways to make the healthcare environment more welcoming to LGBT patients in general include the following [11, 12, 21–23]:
Advertise in local LGBT-friendly papers and online organizations.
Sign up as a provider at the Gay Lesbian Medical Association (GLMA) online web site (http://www.glma.org).
Have LGBT-friendly posters/pictures and literature/handouts in the waiting room.
Prominently display LGBT signs/logos in office or web site, such as rainbow, safe zone, and Human Rights Campaign equality logo.
Provide unisex bathroom for transgender patients.
Train staff and post nondiscrimination policies that include sexual orientation/gender identity.
Have intake/registration forms that are LGBT inclusive.
Adapt culturally competent and open communication/history-taking skills.
Do not assume heterosexuality; use gender-neutral language; don’t be afraid to ask.
Don’t assume all MSM are high risk for STI/HIV; ask about behaviors.
Assure confidentiality; be supportive.
Have a list of LGBT-friendly resources/referrals available to give to patients.
Taking the History
Sexual Orientation/Gender Identity
Before clinicians can provide culturally appropriate healthcare and preventive services, they need to know the sexual orientation/gender identity of the patient sitting in front of them. Sexual minorities are more likely to self-identify by completing an LGBT-inclusive intake form (paper or computer entry) prior to being seen. Asking open-ended, nonjudgmental, gender-neutral questions about their social situation and history establishes a respectful clinician-patient relationship, which is critical to making patients feel comfortable enough to disclose their sexual orientation/gender identity and to discuss their personal health issues. Clinicians can also identify sexual orientation by asking patients whether they have sex with men, women, or both, but taking this approach may not be directly relevant to patients’ reasons for their visits unless they are having sexually related symptoms [24].
Coming-Out/Support Systems
An important component of the gay/bisexual man’s history is whether he has accepted his sexual orientation, a process that usually takes several years, and whether he is “out of the closet” and open to families, friends, co-workers, etc. While identifying negative risk factors is important, it is also important to identify positive support systems. MSM who are “out” are usually better prepared to face negative or hostile environments, have fewer risky behaviors, and have more healthy and productive lives overall [12].
Clinicians can help MSM through the process of self-acceptance and coming out to others, but under no circumstances should clinicians “out” anyone without their permission. For gay and bisexual youth who may face the adverse consequences of nonaccepting parents, an assessment of the home environment prior to coming out is especially important. Community support organizations, such as PFLAG (Parents, Families, and Friends of Lesbians and Gays; https://community.pflag.org), can also assist in personal and family acceptance of one’s sexual orientation and provide connections to others in the gay/bisexual community for additional social support [25].
Sexual History
See Chap. 9 for information and an algorithm for taking the sexual history ; this section will emphasize topics specifically relevant to MSM. The 5 Ps (partners, practices, protection from STIs, past history of STIs, and prevention of pregnancy) is a useful tool/mnemonic for taking the routine sexual history for all patients [8, 26]. After a transition statement that introduces and normalizes the sexual history and assures confidentiality, patients should be asked the following three screening questions:
Have you been sexually active in the last year?
Do you have sex with men, women, or both?
How many people have you had sex within the last year?
Based on the patients’ responses, the clinician can stratify patients into low- and high-risk groups for STI/HIV and follow-up with appropriate questions.
Partners
Many MSMs consistently use safe sex practices or are in long-term, monogamous relationships. However, MSM with multiple or new partners should be screened with additional questions about sexual behaviors.
A specific point to clarify with MSM who state that they have or live with one partner is whether the relationship is monogamous or not. A closed relationship is assumed to be low risk if truly monogamous. Open relationships are those in which one or both partners also have sex with other men or, in the case of bisexual men, with women. Because open relationships vary in what activities are allowed or not, ask the partners to describe their activities to assess their risk.
Practices
Ask about receptive and insertive penile-oral/anal sex and direct oral-anal exposures to determine appropriate STI exposure/testing sites. Questions about injectable drug use help identify viral hepatitis/HIV risks, and substance use during sex may affect judgment and lead to risky sexual behaviors.
Protection from STIs
MSM should be asked about the consistency of condom/barrier use.
Past History of STIs
History of previous STIs and the frequency of STI screening tests are important to assess risk status and the patient’s need and comfort level for ongoing screening.
Pregnancy Plans
Contraception/barrier protection is relevant for the bisexual male.
Finally, clinicians should not forget to ask about sexual function and satisfaction as well as sexual abuse/trauma to complete the sexual history.
Special Health Topics
For the following topics, refer to previous chapters where the topics and their management are discussed in more detail. In this section, issues specifically relevant to MSM are discussed, yet there is overlap with the material provided in the other sections in this textbook that also apply to MSM.
Tobacco Use
Extensive reviews of the literature reveal a strong association of smoking by gay/bisexual men with an odds 2–2.5 times that for heterosexuals [27]. A 2013 national survey found that 26 % of gay men and 29 % of bisexual men smoke compared to 20 % of heterosexual men [28].
Risk factors for smoking by MSM include internalized homophobia, victimization and discrimination, younger age, lower educational level, alcohol use, depression, and stress. Tobacco companies also have specifically targeted the sexual minority population, and the relatively safe haven of bars where MSM congregate and smoking is common has contributed to higher rates of smoking [7].
Dietary Habits
Compared to heterosexual men, eating disorders and body image issues are more common in gay men who are twice as likely to describe themselves as underweight while bisexual men are 2.5 times as likely to think of themselves as overweight. Gay men also have four times the odds of engaging in recent unhealthy weight control behaviors (e.g., fasting, using diet products/laxatives, and purging) [29]. It has been hypothesized that gay men feel greater pressure to be thin than heterosexual males and to achieve the ideal male model look as promoted by the mass media to attract other MSM; the use of performance-enhancing drugs to build muscle ties into the body image problem.
Alcohol/Drug Use
Substance abuse by gay youth is associated with anti-gay school bullying, which leads to associations with other “deviant” peers (defined as those more likely to take risks and not fit in with the norm) [30]. The prevalence in the past year of any substance use disorder was 31.4 % for gay men, 27.6 % for bisexual men, and 15.6 % for heterosexual men [31]. A 2013 national survey found that 39 % of gay men and 52 % of bisexual men drank five or more drinks in one day at least once a year compared to 31 % of heterosexual men [28]. Drugs of abuse are also more commonly used by MSM to manage/reduce stress, and their use may lead to risky sexual behaviors and injuries while under their influence [12].
Mental Health
Substantial mental health disparities exist between gay/bisexual men and heterosexual men including depression, generalized anxiety disorder, panic disorder, eating disorders, and drug and alcohol dependencies; these differences are greater in young gay and bisexual men [32]. Lifetime suicidal ideation and attempts by gay men are 2–4 times greater compared to those of heterosexual men [32, 33], and bisexual men experience more suicide ideation and mental distress than either gay or heterosexual men [34].
Injuries/Violence
Intimate partner violence (IPV) against men partnered with men is up to three times that for men in heterosexual relationships (21.5 % vs. 7.1 %). However, most professionals called upon to assist these men do not receive specific training in sexual minority intimate partner violence management, and few shelters and services are available for this population [35, 36]. Unwanted sex was experienced by 18 % of gay men, 12 % of bisexual men, and 2.2 % of heterosexual men. Childhood violence/maltreatment was recalled by 31.5 % of gay men vs. 19.8 % of heterosexual men [37].
MSM also have more personal violence and knowledge of trauma to close friends/relatives. Types of violence (MSM vs. heterosexuals) include getting beaten (20.7 % vs. 11.7 %), getting mugged (27.5 % vs. 16.2 %), and being stalked (8.1 % vs. 2.6 %) [37]. Gay men have experienced property crime (28.1 %), attempted crime (21.5 %), objects thrown at them (21.1 %), threats of violence (35.4 %), verbal abuse (63.0 %), and employment/housing discrimination (17.7 %); these acts were experienced less often by bisexual men [38].
Crimes against gay men are most often committed by heterosexual men. Gay men are more visible as targets compared to lesbians and bisexuals because gay men are more likely to visit gay-oriented public establishments and to disclose their sexual orientation socially and at work [38].
Sexually Transmitted Infections
STIs, including syphilis, gonorrhea, chlamydia, and HIV, have increased in the past few years for MSM following an increase in unsafe sexual practices. It is believed that some MSM take more risks now because newer HIV medications have changed HIV infection from a death warrant to a chronic, manageable disease. MSM have reported that they also do not like using condoms as they interfere with a feeling of intimacy or they believe that others have the same HIV status as they do and therefore they do not ask about their partner’s status [4, 8, 39]. See Chap. 10 for more details and treatment recommendations.
STI Screening Intervals
STI screening is recommended annually for all sexually active MSM not in a long-term monogamous relationship if they have had exposures during the past year. Screening is recommended every 3–6 months for those at higher risk who had multiple or anonymous partners or sexual experiences in which either partner used alcohol or illicit drugs [4].
Gonorrhea/Chlamydia
While most urethral infections in men are symptomatic, most extragenital gonorrhea/chlamydia infections do not have any symptoms or signs, or they produce mild symptoms that are often ignored [40]. Up to 50 % of chlamydia infections and about 85 % of rectal infections are asymptomatic in men while 53 % of chlamydial and 64 % of gonococcal infections are found in non-urethral sites [40, 41]. In one study of asymptomatic MSM, chlamydia was found in 7.9 % of rectal, 5.2 % of urethral, and 1.4 % of pharyngeal sites while gonorrhea was found in 6.9 % of rectal, 6.0 % of urethral, and 9.2 % of pharyngeal sites [41]. As a result, many infected yet asymptomatic men do not seek treatment and continue to spread the infection.
In screening asymptomatic MSM for gonorrhea and chlamydia, it is important to test not only the urethra/urine (MSM who have insertive penile-oral or penile-anal sex) but also the rectum (MSM who have receptive penile-anal sex) and the pharynx (MSM who have receptive penile-oral sex or direct oral-anal contact). A nucleic acid amplification test (NAAT) is preferred for all testing but especially for extragenital testing because of its greater sensitivity and specificity as compared to culture for those sites [12, 42]. Those with HIV should be tested for gonorrhea/chlamydia quarterly as the incidence is higher in HIV-infected persons (one in seven has asymptomatic infections with 60 % of infections occurring in the pharynx and rectum) [42, 43].
Syphilis
Hepatitis A
Hepatitis A is usually an acute, self-limited infection with fecal-oral transmission. MSM can become infected by sexual activity or direct contact with contaminated fingers or objects. Of new hepatitis A cases, 10 % are estimated to occur in MSM [4]. Testing should only be performed when clinically indicated. Hepatitis A vaccination is recommended as part of the routine childhood immunization schedule and is recommended for MSM at any age if they have not been previously vaccinated [14].
Hepatitis B
Hepatitis B is spread by semen or blood and is easily transmitted during sex, being 50–100 times as infectious as HIV. Tattoos and piercings done with infected equipment and injectable drug use are other sources of infection. Hepatitis B can present as an acute infection but also as a chronic asymptomatic infection leading to severe liver damage. Of new hepatitis B cases, 20 % are estimated to occur in MSM. Hepatitis B vaccination is recommended as part of the routine childhood immunization schedule and is recommended for MSM at any age if they have not been previously vaccinated [4, 14].
Hepatitis C
Sexual transmission of hepatitis C is not common but does occur, especially among MSM with HIV infection who should be screened periodically. Other risk factors include having another STI, sex with multiple partners, or rough sex. More commonly hepatitis C is spread through contaminated needles used for injectable drugs, piercings, and tattoos [4]. No vaccine for hepatitis C is currently available.
Human Papillomavirus
Approximately 75 % of all sexually active adults acquire HPV, often within the first 2 years of starting sexual activity. About 57–61 % of HIV-negative MSM and 72–90 % of HIV-positive MSM will have HPV [44]. Infections are usually asymptomatic, but when symptomatic, HPV expresses itself as genital/anal warts. Because HPV can be spread by direct skin-to-skin contact, condom use is less effective. Multiple partners, alcohol and illicit drug use, and smoking are risk factors [45].
HPV vaccine is recommended for all males and ideally should be given before the onset of sexual activity at age 11–12 years, but it can be given through age 26 years for MSM [14]. Evidence exists that giving HPV vaccine to MSM older than 26 years may be beneficial, but additional studies are needed to confirm this finding [46].
Human Immunodeficiency Virus
MSM account for about two-thirds of new HIV cases with 4 % derived from injection drug use. The incidence of HIV has increased 12 % from 2008 to 2010 for MSM, especially in adolescent and young adult MSM (22 % increase). MSM make up over one-half of all persons with HIV in the USA, and about one-third do not know that they are infected [4].
Postexposure Prophylaxis (PEP)
An antiretroviral regimen of three drugs (tenofovir, emtricitabine, and raltegravir; alternative regimens are also available) should be started within 72 h after an HIV exposure and continued for 28 days. Periodic HIV testing is recommended at 1, 3, and 6 months following the exposure [15]. Those with recurrent exposures should consider preexposure prophylaxis (see below).
Preexposure Prophylaxis (PrEP)
The Centers for Disease Control and Prevention (CDC) [15] and World Health Organization (WHO) [47] recommend that MSM and others whose behaviors place them at a significant risk of getting HIV infection consider the benefits of taking the once-daily antiretroviral combination of tenofovir and emtricitabine. If taken daily, PrEP can reduce the risk of infection up to 92 % without significant complications. A clinical practice guideline [16] and provider’s supplement [48] for PrEP were issued in 2014 by the US Public Health Service and include criteria for determining HIV risk and a comprehensive program of every 3-month STI/HIV testing, side effect monitoring, and safe sex counseling [15].
Criteria for taking PrEP for MSM include all of the following [16]:
Adult man age 18 and older
Without acute or established HIV infection
Any male sex partners in the past 6 months
Not in a monogamous partnership with a recently tested, HIV-negative man
And at least one of the following:
Any anal sex without condoms (receptive or insertive) in the past 6 months
Any STI diagnosed or reported in past 6 months
Is in an ongoing sexual relationship with an HIV-positive male partner
Insurance companies generally are covering the cost of PrEP with the rationale that preventing HIV infections is cheaper than treating HIV/AIDS. The manufacturer (Gilead) also has an online medication assistance program for those without insurance and co-pay assistance for those with insurance.
Anal Cancer
Anal cancer and cervical cancer are caused by the same strains of HPV (see above). Proponents argue for anal Pap screening based on the model for cervical screening and the higher incidence of anal cancer in MSM (20 times) and especially in MSM with HIV (40 times) [45]. However, progression of anal cancer precursors to cancer appears to be much lower than for cervical cancer. No definitive evidence exists that screening reduces the incidence of anal cancer and well-designed prospective trials are needed [49].